Results 111 to 120 of about 8,420 (174)

Myasthenia Gravis and Thymoma

Muscle &Nerve, Volume 74, Issue 4, Page 1156-1173, October 2026.
ABSTRACT Thymoma is the most common tumor of the anterior mediastinum. Approximately 20%–30% of patients with a thymoma develop myasthenia gravis (MG), and an additional one third may possess positive acetylcholine receptor (AChR) antibodies without MG.
Benjamin Claytor, Lukas Delasos, Daniel P. Raymond, Erik Seroogy, Jason Lempel, Yuebing Li   +5 more
wiley   +1 more source

Lumbosacral Plexopathy: A Single‐Center Review of Etiology, Clinical Presentation, Electrodiagnostic Findings, and Long‐Term Outcomes

Muscle &Nerve, Volume 74, Issue 4, Page 1220-1229, October 2026.
ABSTRACT Introduction/Aims Lumbosacral plexopathy (LSP) results from a spectrum of etiologies and can cause substantial functional impairment. Limited data exist on the relative distribution of etiologies and outcomes across broad tertiary‐care cohorts spanning multiple causes of LSP.
Bradley Ong, Jad El Ahdab, Nicolas Thompson, Yuebing Li, Nirmal Andrapalliyal   +4 more
wiley   +1 more source

Mechanism‐Informed Pharmacotherapy Optimization and Deprescribing: A Redox–Mitochondrial Framework

Pharmacology Research &Perspectives, Volume 14, Issue 5, October 2026.
From cumulative drug burden to mitochondrial stress and functional decline. The graphical abstract summarizes the central concept of the review, illustrating how cumulative pharmacotherapy exposure may contribute to redox–mitochondrial stress and thereby reduce biological and functional resilience.
Boštjan Martinc
wiley   +1 more source

When Numbness and Tingling Play a Role-Sexual Function in Compressive Neuropathy. [PDF]

J Hand Surg Glob Online
Bridges TN, Kohring AS, Kasper AA, Kachooei AR, Tosti R, Rivlin M.   +5 more
europepmc   +1 more source

Unusual olecranon mass with ulnar nerve compressive neuropathy caused by a haemophilic pseudotumour. [PDF]

BMJ Case Rep, 2019
Yeung CM, Blazar P.
europepmc   +1 more source

Driving Drugs Deeper: Force‐Driven Microneedle Systems for Active Therapy and Their Road Towards Clinical Implementation

Small, Volume 22, Issue 55, 1 October 2026.
Force‐driven microneedles are presented as active therapeutic microdevices that overcome the diffusion limits of conventional patches. By integrating gas generation, magnetic actuation, cavitation, or iontophoresis, these systems drive payloads deeper into tissue, enabling faster, more controlled delivery and highlighting key design principles and ...
Majed Amini, Phoebe Li, Hamed Shahsavan, Mahla Poudineh   +3 more
wiley   +1 more source

Oculomotor compressive neuropathy secondary to calcifying pseudoneoplasm of the neuraxis (CAPNON). [PDF]

J Surg Case Rep
Alzate-Carvajal V, Madriñán-Navia HJ, Escobar LA, Moreno-Huertas CE.   +3 more
europepmc   +1 more source

A Composite Ovine Forestomach Matrix and Hyaluronic Acid CAMP for the Treatment of Full Thickness Wounds of the Foot in People With Diabetes: A Randomized Controlled Trial

International Wound Journal, Volume 23, Issue 10, October 2026.
ABSTRACT Diabetic foot ulcers (DFUs) are a devastating complication of diabetes that markedly affects quality of life and generates significant socioeconomic and healthcare burdens. When DFUs fail to respond to standard of care (SOC), advanced therapies including Cellular, Acellular and Matrix‐like Products (CAMPs) are often employed. A novel composite
David G. Armstrong, Dennis P. Orgill, Robert D. Galiano, John C. Lantis, Paul Glat, Alexander M. Reyzelman, Robert J. Snyder, Adam L. Isaac, Marissa J. Carter, Charles M. Zelen   +9 more
wiley   +1 more source

A Prospective Cohort Study of Hard‐to‐Heal Chronic Foot and Leg Wounds Followed for up to 20 Weeks After Initiation of ReGenerating Tissue Agents (RGTA) Technology as an Add‐on to Optimal Local Care

International Wound Journal, Volume 23, Issue 10, October 2026.
ABSTRACT ReGenerating Tissue Agents (RGTA, trade name CACIPLIQ20) contain a structural analogue of heparan sulfates (HSs) that promotes tissue regeneration in hard‐to‐heal chronic wounds resistant to the best standard of care for 6 months or longer.
Serge Ynesta, Marion Mourgues, Chloé Geri, Martin Inizan, Denis Barritault, Frédéric Sedel, Jean‐Charles Kerihuel, Luc Téot   +7 more
wiley   +1 more source